8k8s
F8-A22-E4 complex of MPXV in complex with DNA and Ara-CTPF8-A22-E4 complex of MPXV in complex with DNA and Ara-CTP
Structural highlights
FunctionPublication Abstract from PubMedThere are three key components at the core of the mpox virus (MPXV) DNA polymerase holoenzyme: DNA polymerase F8, processivity factors A22, and the Uracil-DNA glycosylase E4. The holoenzyme is recognized as a vital antiviral target because MPXV replicates in the cytoplasm of host cells. Nucleotide analogs such as cidofovir and cytarabine (Ara-C) have shown potential in curbing MPXV replication and they also display promise against other poxviruses. However, the mechanism behind their inhibitory effects remains unclear. Here, we present the cryo-EM structure of the DNA polymerase holoenzyme F8/A22/E4 bound with its competitive inhibitor Ara-C-derived cytarabine triphosphate (Ara-CTP) at an overall resolution of 3.0 A and reveal its inhibition mechanism. Ara-CTP functions as a direct chain terminator in proximity to the deoxycytidine triphosphate (dCTP)-binding site. The extra hydrogen bond formed with Asn665 makes it more potent in binding than dCTP. Asn665 is conserved among eukaryotic B-family polymerases. Structural basis for the inhibition mechanism of the DNA polymerase holoenzyme from mpox virus.,Shen Y, Li Y, Yan R Structure. 2024 Mar 26:S0969-2126(24)00086-8. doi: 10.1016/j.str.2024.03.004. PMID:38579705[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
|